Variant report

Variant	nsv997958
Chromosome Location	chr2:20349343-20386339
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:994)
CpG islands
(count:367)
Chromatin interactive
region (count:70)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:994 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:20372324-20372649	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:20386226-20386632	HepG2	liver:	n/a	n/a
3	ARID3A	chr2:20383924-20384238	HepG2	liver:	n/a	n/a
4	ARID3A	chr2:20356882-20357084	HepG2	liver:	n/a	n/a
5	ARID3A	chr2:20382099-20382453	K562	blood:	n/a	n/a
6	ARID3A	chr2:20377549-20377680	HepG2	liver:	n/a	n/a
7	ARID3A	chr2:20379543-20379887	HepG2	liver:	n/a	n/a
8	ATF2	chr2:20350999-20351524	GM12878	blood:	n/a	n/a
9	ATF2	chr2:20356951-20357553	GM12878	blood:	n/a	n/a
10	ATF2	chr2:20350891-20351453	GM12878	blood:	n/a	n/a
11	ATF3	chr2:20386320-20386576	K562	blood:	n/a	n/a
12	ATF3	chr2:20379356-20379998	A549	lung:	n/a	n/a
13	ATF3	chr2:20381911-20382891	A549	lung:	n/a	n/a
14	ATF3	chr2:20386224-20386648	GM12878	blood:	n/a	n/a
15	ATF3	chr2:20386266-20386589	HepG2	liver:	n/a	n/a
16	BCL11A	chr2:20351016-20351358	GM12878	blood:	n/a	n/a
17	BCL11A	chr2:20351069-20351364	GM12878	blood:	n/a	n/a
18	BCL3	chr2:20377831-20378212	GM12878	blood:	n/a	n/a
19	BCL3	chr2:20351012-20351439	GM12878	blood:	n/a	n/a
20	BCL3	chr2:20366414-20366928	GM12878	blood:	n/a	n/a
21	BCL3	chr2:20379064-20380150	A549	lung:	n/a	chr2:20379666-20379679
22	BCL3	chr2:20364089-20366232	A549	lung:	n/a	n/a
23	BCLAF1	chr2:20350883-20351461	GM12878	blood:	n/a	n/a
24	BCLAF1	chr2:20350994-20351407	GM12878	blood:	n/a	n/a
25	BCLAF1	chr2:20365821-20366405	GM12878	blood:	n/a	chr2:20366229-20366238
26	BHLHE40	chr2:20365724-20365909	K562	blood:	n/a	n/a
27	BHLHE40	chr2:20351067-20351412	GM12878	blood:	n/a	n/a
28	BHLHE40	chr2:20382274-20382765	K562	blood:	n/a	n/a
29	BHLHE40	chr2:20377992-20378136	K562	blood:	n/a	n/a
30	BHLHE40	chr2:20357067-20357469	GM12878	blood:	n/a	n/a
31	BHLHE40	chr2:20386024-20386631	K562	blood:	n/a	n/a
32	BHLHE40	chr2:20364518-20364923	GM12878	blood:	n/a	n/a
33	BHLHE40	chr2:20372252-20372519	HepG2	liver:	n/a	chr2:20372393-20372409
34	BRCA1	chr2:20377707-20377750	HepG2	liver:	n/a	n/a
35	BRCA1	chr2:20384009-20384010	HepG2	liver:	n/a	n/a
36	CBX3	chr2:20382139-20382734	K562	blood:	n/a	n/a
37	CBX3	chr2:20364573-20364958	K562	blood:	n/a	n/a
38	CBX3	chr2:20349902-20350272	K562	blood:	n/a	n/a
39	CBX3	chr2:20386139-20386651	K562	blood:	n/a	n/a
40	CCNT2	chr2:20382326-20382550	K562	blood:	n/a	n/a
41	CEBPB	chr2:20351519-20351569	HepG2	liver:	n/a	chr2:20351521-20351532
42	CEBPB	chr2:20383898-20384269	HepG2	liver:	n/a	chr2:20384073-20384084
43	CEBPB	chr2:20379473-20379811	Hela-S3	cervix:	n/a	chr2:20379649-20379660
44	CEBPB	chr2:20379443-20379782	HepG2	liver:	n/a	chr2:20379649-20379660
45	CEBPB	chr2:20382470-20382596	K562	blood:	n/a	n/a
46	CEBPB	chr2:20382535-20382538	HepG2	liver:	n/a	n/a
47	CEBPB	chr2:20366015-20366904	A549	lung:	n/a	n/a
48	CEBPB	chr2:20380073-20380407	HepG2	liver:	n/a	n/a
49	CEBPB	chr2:20351516-20351543	Hela-S3	cervix:	n/a	chr2:20351521-20351532
50	CEBPB	chr2:20350870-20351440	GM12878	blood:	n/a	n/a

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:20384285-20384335	PANC-1	pancreas:	n/a
2	chr2:20384285-20384335	PANC-1	pancreas:	n/a
3	chr2:20370392-20370442	MCF-7	breast:	n/a
4	chr2:20357306-20357356	MCF10A-Er-Src	breast:	n/a
5	chr2:20357306-20357356	PrEC	prostate:	n/a
6	chr2:20384285-20384335	SKMC	muscle:	n/a
7	chr2:20371971-20372021	HEEpiC	esophagus:	n/a
8	chr2:20384285-20384335	Caco-2	colon:	n/a
9	chr2:20370392-20370442	AoSMC	blood vessel:	n/a
10	chr2:20384285-20384335	Hela-S3	cervix:	n/a
11	chr2:20370392-20370442	GM12891	blood:	n/a
12	chr2:20371971-20372021	MCF-7	breast:	n/a
13	chr2:20357306-20357356	SK-N-MC	brain:	n/a
14	chr2:20384285-20384335	IMR90	lung:	fetal
15	chr2:20384285-20384335	HNPCEpiC	eye:	n/a
16	chr2:20357306-20357356	LNCaP	prostate:	n/a
17	chr2:20349535-20349585	PFSK-1	brain:	n/a
18	chr2:20349535-20349585	AG10803	skin:	n/a
19	chr2:20357306-20357356	HNPCEpiC	eye:	n/a
20	chr2:20370392-20370442	HCF	heart:	n/a
21	chr2:20370392-20370442	GM12878	blood:	n/a
22	chr2:20366443-20366493	HRE	kidney:	n/a
23	chr2:20357306-20357356	HCM	heart:	n/a
24	chr2:20384285-20384335	NHBE	bronchial:	n/a
25	chr2:20349535-20349585	BJ	skin:	n/a
26	chr2:20349535-20349585	SK-N-MC	brain:	n/a
27	chr2:20371971-20372021	Caco-2	colon:	n/a
28	chr2:20366443-20366493	IMR90	lung:	fetal
29	chr2:20371971-20372021	SAEC	small airway:	n/a
30	chr2:20357306-20357356	Hela-S3	cervix:	n/a
31	chr2:20370392-20370442	HAEpiC	amniotic membrane:	n/a
32	chr2:20366443-20366493	GM06990	blood:	n/a
33	chr2:20384285-20384335	SAEC	small airway:	n/a
34	chr2:20349535-20349585	HMEC	breast:	n/a
35	chr2:20371971-20372021	T-47D	breast:	n/a
36	chr2:20349535-20349585	U87	brain:	n/a
37	chr2:20349535-20349585	H1-hESC	embryonic stem cell:	embryo
38	chr2:20371971-20372021	Hela-S3	cervix:	n/a
39	chr2:20357306-20357356	NB4	blood:	n/a
40	chr2:20384285-20384335	HEK293	kidney:	embryo
41	chr2:20384285-20384335	U87	brain:	n/a
42	chr2:20370392-20370442	GM06990	blood:	n/a
43	chr2:20371971-20372021	HCM	heart:	n/a
44	chr2:20366443-20366493	PrEC	prostate:	n/a
45	chr2:20366443-20366493	NHBE	bronchial:	n/a
46	chr2:20357306-20357356	HPAEpiC	pulmonary alveolar:	n/a
47	chr2:20370392-20370442	HCT-116	colon:	n/a
48	chr2:20384285-20384335	AG09319	gingival:	n/a
49	chr2:20366443-20366493	NB4	blood:	n/a
50	chr2:20384285-20384335	NHDF-neo	bronchial:	n/a

(count:70 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr2:20342469..20346864-chr2:20382569..20386022,5	MCF-7	breast:
2	chr2:20364675..20367244-chr2:20367416..20369596,2	K562	blood:
3	chr2:20372315..20374998-chr2:20375202..20377674,2	MCF-7	breast:
4	chr2:20362106..20364188-chr2:20366369..20369040,2	MCF-7	breast:
5	chr2:20348330..20350992-chr2:20378144..20381464,4	MCF-7	breast:
6	chr2:20375045..20377368-chr2:20378301..20380397,2	K562	blood:
7	chr2:20343897..20346310-chr2:20367652..20370210,2	MCF-7	breast:
8	chr2:20380951..20386083-chr2:20391129..20397009,8	MCF-7	breast:
9	chr2:20366533..20369508-chr2:20380029..20382114,2	MCF-7	breast:
10	chr2:20357950..20360555-chr2:20362622..20364914,3	MCF-7	breast:
11	chr2:20337465..20342202-chr2:20382545..20388364,6	MCF-7	breast:
12	chr2:20357663..20359639-chr2:20362711..20364978,2	K562	blood:
13	chr2:20309325..20314922-chr2:20379425..20384303,7	MCF-7	breast:
14	chr2:20378964..20381641-chr2:20471495..20474271,2	MCF-7	breast:
15	chr2:20366533..20369508-chr2:20380029..20382114,2	MCF-7	breast:
16	chr2:20359744..20361850-chr2:20371412..20373041,2	MCF-7	breast:
17	chr2:20364027..20368295-chr2:20377113..20381748,5	MCF-7	breast:
18	chr2:20357663..20359639-chr2:20362711..20364978,2	K562	blood:
19	chr2:20348708..20350605-chr2:20350801..20352836,2	MCF-7	breast:
20	chr2:20343488..20346809-chr2:20347899..20350701,3	MCF-7	breast:
21	chr2:20348330..20350992-chr2:20378144..20381464,4	MCF-7	breast:
22	chr2:20379159..20380103-chr2:20424857..20425621,3	MCF-7	breast:
23	chr2:20380124..20381774-chr2:20398168..20400030,2	MCF-7	breast:
24	chr2:20366147..20368368-chr2:20415586..20417297,2	MCF-7	breast:
25	chr2:20307232..20308797-chr2:20378092..20380183,2	MCF-7	breast:
26	chr2:20339624..20342165-chr2:20377427..20379627,2	MCF-7	breast:
27	chr2:20306400..20314350-chr2:20385971..20392665,10	MCF-7	breast:
28	chr2:20378488..20380865-chr2:38320846..38323560,2	MCF-7	breast:
29	chr2:20369269..20371931-chr2:20376136..20379582,4	MCF-7	breast:
30	chr2:20368602..20370551-chr2:20379312..20381264,2	MCF-7	breast:
31	chr2:20364675..20367244-chr2:20367416..20369596,2	K562	blood:
32	chr2:20365445..20367731-chr2:20374746..20377053,2	MCF-7	breast:
33	chr2:20368602..20370551-chr2:20379312..20381264,2	MCF-7	breast:
34	chr2:20364027..20368295-chr2:20377113..20381748,5	MCF-7	breast:
35	chr2:20364604..20368497-chr2:20376297..20379611,4	MCF-7	breast:
36	chr2:20386118..20389028-chr2:20389700..20391555,2	K562	blood:
37	chr2:20251074..20253926-chr2:20378631..20381986,3	MCF-7	breast:
38	chr2:20357867..20361312-chr2:20362237..20365220,4	MCF-7	breast:
39	chr2:20352822..20355874-chr2:20423290..20424865,3	MCF-7	breast:
40	chr2:20359744..20361850-chr2:20371412..20373041,2	MCF-7	breast:
41	chr2:20347344..20349010-chr2:20367659..20370421,2	MCF-7	breast:
42	chr2:20301825..20304525-chr2:20380174..20381913,2	MCF-7	breast:
43	chr2:20364604..20368497-chr2:20376297..20379611,4	MCF-7	breast:
44	chr2:20384920..20386704-chr2:20549838..20552413,2	MCF-7	breast:
45	chr2:20248476..20251356-chr2:20368246..20369984,2	MCF-7	breast:
46	chr2:20100444..20102626-chr2:20384873..20387447,2	K562	blood:
47	chr2:20101674..20103205-chr2:20369213..20371363,2	MCF-7	breast:
48	chr2:20368402..20370917-chr2:20372413..20374946,2	K562	blood:
49	chr2:20357950..20360555-chr2:20362622..20364914,3	MCF-7	breast:
50	chr2:20348708..20350605-chr2:20350801..20352836,2	MCF-7	breast:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SDC1-1	chr2:20380060-20380264	NONHSAT069430
2	lnc-RHOB-11	chr2:20384172-20384343	NONHSAT069431
3	lnc-RHOB-11	chr2:20382137-20382704	NONHSAT069431
4	lnc-RHOB-12	chr2:20375107-20375397	NONHSAT069428
5	lnc-SDC1-1	chr2:20378877-20378886	NONHSAT069430

No data

Variant related genes	Relation type
RN7SL140P	TF binding region
ENSG00000213729	TF binding region
RNU6-961P	TF binding region
RN7SL140P	CpG island
ENSG00000213729	CpG island
RNU6-961P	CpG island
ENSG00000068697	chromatin interactions
ENSG00000266059	chromatin interactions
ENSG00000055917	chromatin interactions
ENSG00000183891	chromatin interactions
ENSG00000223734	chromatin interactions
ENSG00000115884	chromatin interactions
ENSG00000200763	chromatin interactions
ENSG00000271991	chromatin interactions
ENSG00000234378	chromatin interactions

Extended variants
information (count: 1527 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:1527 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs565156714	chr2:20349361-20349362	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
2	rs573471715	chr2:20349366-20349367	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
3	rs545673017	chr2:20349394-20349395	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs558589880	chr2:20349400-20349401	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
5	rs575357364	chr2:20349421-20349422	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs544216538	chr2:20349422-20349423	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
7	rs528997822	chr2:20349424-20349425	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
8	rs11685359	chr2:20349433-20349434	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs565679629	chr2:20349444-20349445	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
10	rs560261189	chr2:20349447-20349448	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
11	rs143595441	chr2:20349476-20349477	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
12	rs7600854	chr2:20349503-20349504	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs191419558	chr2:20349513-20349514	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
14	rs576120977	chr2:20349524-20349525	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
15	rs183337654	chr2:20349531-20349532	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
16	rs114578716	chr2:20349539-20349540	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
17	rs187874411	chr2:20349540-20349541	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
18	rs571500945	chr2:20349542-20349543	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
19	rs191137470	chr2:20349544-20349545	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
20	rs536875526	chr2:20349558-20349559	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
21	rs539231859	chr2:20349577-20349578	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
22	rs28628174	chr2:20349590-20349591	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs556733465	chr2:20349632-20349633	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
24	rs151018207	chr2:20349634-20349635	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
25	rs140896253	chr2:20349652-20349653	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
26	rs554523656	chr2:20349699-20349700	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
27	rs576168509	chr2:20349707-20349708	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
28	rs541928862	chr2:20349768-20349769	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
29	rs576996753	chr2:20349801-20349802	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs560092417	chr2:20349874-20349875	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs576675464	chr2:20349915-20349916	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs545586423	chr2:20349928-20349929	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs11686716	chr2:20349985-20349986	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs531472974	chr2:20350025-20350026	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs36087806	chr2:20350078-20350079	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs182144968	chr2:20350094-20350095	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs561292651	chr2:20350099-20350100	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs370066939	chr2:20350162-20350163	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs375235658	chr2:20350177-20350178	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs530137769	chr2:20350200-20350201	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs547117659	chr2:20350218-20350219	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs199825122	chr2:20350222-20350223	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs187917102	chr2:20350275-20350276	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs539269085	chr2:20350304-20350305	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs368561345	chr2:20350347-20350348	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs115927104	chr2:20350352-20350353	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs6738744	chr2:20350417-20350418	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs150078022	chr2:20350485-20350486	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs16987418	chr2:20350494-20350495	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs375960559	chr2:20350565-20350566	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Neuroblastoma	21508638	CNVD
Breast cancer	17603634	CNVD
Cancer	16751803	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Ependymoma	16718352	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	20607354	CNVD
Neuroblastoma	19638189	CNVD
Neuroblastoma	19435921	CNVD
Neuroblastoma	18574593	CNVD
Acute myeloid leukemia	18000384	CNVD
Medulloblastoma	16968546	CNVD
Medulloblastoma	22160402	CNVD
Schizophrenia	22118685	CNVD
Epilepsy	22118685	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Leukemia	18628472	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Ovarian cancer	17908972	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	18765546	CNVD
Neuroblastoma	18281664	CNVD
Neuroblastoma	17289879	CNVD
Neuroblastoma	19738985	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	21364760	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:767 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:20332200-20364400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr2:20345600-20349800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr2:20345600-20356600	Weak transcription	Liver	Liver
4	chr2:20346000-20349400	Weak transcription	Fetal Muscle Trunk	muscle
5	chr2:20346000-20355600	Weak transcription	Esophagus	oesophagus
6	chr2:20346800-20352800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr2:20348000-20349400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr2:20348000-20349600	Enhancers	Brain Germinal Matrix	brain
9	chr2:20348000-20349800	Enhancers	ES-I3 Cell Line	embryonic stem cell
10	chr2:20348000-20349800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
11	chr2:20348000-20351200	Enhancers	HUES64 Cell Line	embryonic stem cell
12	chr2:20348000-20351400	Enhancers	HSMM	muscle
13	chr2:20348200-20349400	Weak transcription	Lung	lung
14	chr2:20348200-20349600	Enhancers	Fetal Kidney	kidney
15	chr2:20348200-20349800	Enhancers	iPS-15b Cell Line	embryonic stem cell
16	chr2:20348200-20350000	Enhancers	HUES6 Cell Line	embryonic stem cell
17	chr2:20348200-20351200	Enhancers	iPS-18 Cell Line	embryonic stem cell
18	chr2:20348400-20349400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
19	chr2:20348400-20349600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
20	chr2:20348400-20349600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr2:20348400-20349600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr2:20348400-20349600	Enhancers	Cortex derived primary cultured neurospheres	brain
23	chr2:20348400-20349600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr2:20348400-20349600	Enhancers	K562	blood
25	chr2:20348400-20349600	Flanking Active TSS	NH-A	brain
26	chr2:20348400-20349800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr2:20348400-20349800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
28	chr2:20348400-20350000	Enhancers	HMEC	breast
29	chr2:20348400-20350000	Enhancers	NHLF	lung
30	chr2:20348400-20350400	Enhancers	H1 Cell Line	embryonic stem cell
31	chr2:20348400-20351200	Enhancers	Fetal Lung	lung
32	chr2:20348400-20351400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
33	chr2:20348600-20349400	Enhancers	Fetal Intestine Small	intestine
34	chr2:20348600-20349600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
35	chr2:20348600-20349600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
36	chr2:20348600-20349600	Enhancers	Breast Myoepithelial Primary Cells	Breast
37	chr2:20348600-20349600	Enhancers	Adipose Nuclei	Adipose
38	chr2:20348600-20349600	Enhancers	A549	lung
39	chr2:20348600-20349600	Enhancers	Hela-S3	cervix
40	chr2:20348600-20349800	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
41	chr2:20348600-20349800	Enhancers	Duodenum Mucosa	Duodenum
42	chr2:20348600-20349800	Enhancers	Placenta	Placenta
43	chr2:20348600-20349800	Flanking Active TSS	Osteobl	bone
44	chr2:20348600-20350000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
45	chr2:20348600-20350000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
46	chr2:20348600-20351000	Enhancers	H9 Cell Line	embryonic stem cell
47	chr2:20348600-20351200	Enhancers	Fetal Brain Female	brain
48	chr2:20348600-20351200	Enhancers	Fetal Muscle Leg	muscle
49	chr2:20348800-20349400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
50	chr2:20348800-20349400	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links